Related Experiment Video
Updated: May 31, 2026

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
Published on: June 16, 2023
Freezing of gait and activity limitations in people with Parkinson's disease
Dawn M Tan1, Jennifer L McGinley, Mary E Danoudis
1School of Health Sciences, University of Melbourne, Melbourne, Australia. dawn.tan.m.l@sgh.com.sg
Objectives:
To investigate the relationships between freezing of gait (FOG) and activity limitations in ambulant people with Parkinson's disease (PD), and to explore the contribution of FOG and gait hypokinesia to activity limitations after adjusting for the effects of disease severity.
Design:
Retrospective, cross-sectional design.
Setting:
Participants were recruited from neurologists' clinics and the general public in metropolitan Melbourne, Australia.
Participants:
Volunteers were screened for eligibility using the following inclusion criteria: diagnosis of idiopathic PD, modified Hoehn and Yahr stages 0 to IV, without dementia. Participants (N=210) were tested (mean age ± SD, 67.9±9.6y; mean PD duration ± SD, 6.7±5.6y; median Hoehn and Yahr stage=2.5).
Interventions:
Not applicable.
Main Outcome Measures:
FOG was measured using the FOG questionnaire. Gait hypokinesia was quantified using both the 6-meter walk test and the Timed Up and Go test. Activity limitation was measured using the modified Unified Parkinson's Disease Rating Scale activities of daily living (ADL) section and the Schwab and England ADL scale.
Results:
Severity of gait freezing correlated significantly with the level of activity limitation (Spearman correlation coefficient, ρ=-.49 to .48; P<.001). A hierarchic regression model showed that disease severity explained 37.5% of the variance in Schwab and England ADL score (P<.001). Gait hypokinesia and FOG severity scores explained an additional 9.1% of the variance in activity limitation (R(2) change=.091; P<.001).
Conclusions:
FOG severity and gait hypokinesia were associated with reduced levels of activity after adjusting for disease severity.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

